Follicum receives Vinnova grant to study binding of compay’s proprietary FOL peptides to pancreatic cell receptors
Follicum ("Follicum" or "the Company") today announces that the company’s grant application to Vinnova to study binding of FOL peptides to receptors on pancreatic cells has been approved. Follicum is the coordinator of the project, which also includes Lund University and SARomics Biostructures. Parts of the project involve advanced analysis work to be performed at the new MAX IV synchrotron facility in Lund.The application has been submitted within the framework of Vinnova's call for "Industrial pilot projects for the utilisation of neutron and photon based techniques at large-scale